Steroid withdrawal fivedays after renal transplantation allows for the prevention of wound-healing complications associated with sirolimus therapy

Clinical Transplantation

Volumn 23, Issue 1, 2009, Pages 16-22

  Sandrini, Silvio ^a   Setti, Gisella ^a   Bossini, Nicola ^a   Maffei, Camilla ^a   Iovinella, Lucia ^a   Tognazzi, Nadia ^a   Maffeis, Roberto ^a   Nodari, Franco ^a   Portolani, Nazario ^a   Cancarini, Giovanni ^a  

^a SPEDALI CIVILI   (Italy)

Author keywords

Kidney transplantation; Lymphocele; Sirolimus; Steroid withdrawal; Wound complication

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BASILIXIMAB; CEFOTAXIME; CREATININE; CYCLOSPORIN; METHYLPREDNISOLONE; RAPAMYCIN; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGE; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DOSAGE SCHEDULE COMPARISON; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAFT INFECTION; GRAFT RECIPIENT; HEMATOMA; HEMODIALYSIS; HUMAN; INCIDENCE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LOADING DRUG DOSE; LYMPHOCELE; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEROMA; TREATMENT DURATION; WOUND DEHISCENCE; WOUND HEALING IMPAIRMENT; DRUG EFFECT; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGY; KIDNEY FUNCTION TEST; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; WOUND HEALING;

CYCLOSPORINE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; METHYLPREDNISOLONE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; SIROLIMUS; SURVIVAL RATE; TACROLIMUS; TREATMENT OUTCOME; WOUND HEALING;

EID: 63349108547     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2008.00890.x     Document Type: Article

References (19)

1. Hariharan S, Johnson CP, Bresnahan BA et.al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000: 342: 605.
2. Brennan DC. Long-term trends in allograft survival. Adv Chronic Kidney Dis 2006: 13: 11.
3. Hernandez D, Rufino M, Armas S et al. Retrospective analysis of surgical complications following cadaveric kidney transplantation in the modern era. Nephrol Dial Transplant 2006: 21: 2908.
4. Flechner SM, Zhou L, Derweesh I et al. The impact of sirolimus, mycophenolate mofetil, cyclospeorine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients. Transplantation 2003: 76: 1729.
5. Dean PG, Lund W, Larson TS et al. Wound-healing complications after kidney transplantation: A prospective, randomised comparison of sirolimus and tacrolimus. Transplantation 2004: 77: 1555.
6. Langer RM, Kahan BD. Incidence, therapy, and conseguences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients. Transplantation 2002: 74: 804.
7. MacDonald AS. A world-wide, phase III, randomised, controlled, safety, and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts: Rapamune Global Study Group. Transplantation 2001: 71: 271.
8. Mulay AV, Hussain N, Fergusson D, Knoll GA. Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: A systematic review of randomised trials. Am J Transplant 2005: 5: 1748.
9. Mendez R, Gonwa T, Yang HC et al. A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: Results at 1 year. Transplantation 2005: 80: 303.
10. Kihara A, Kasamaki S, Kamano T et al. Abdominal wound dehiscence in patients receiving long-term steroid treatment. J Int Med Res 2006: 34: 223.
11. Leibovich SJ, Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol 1975: 78: 71.
12. Ehrlich HP, Tarver H, Hunt TK. Effects of vitamin A and glucocorticoids upon inflammation and collagen synthesis. Ann Surg 1973: 177: 222.
13. Valente JF, Hriciket D, Weigel K et al. Comparison of sirolimus vs. mycophenolate mofetil on sugical complications and wound healing in adult kidney transplantation. Am J Transplant 2003: 3: 1128.
14. Troppmann C, Pierce JL, Gandhi MM et al. Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: A matched-pair pilot study. Transplantation 2003: 76: 426.
15. Rogers CC, Hanaway M, Alloway RR et al. Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy. Transpl Proc 2005: 37: 795.
16. Cancarini GC, Sandrini S, Setti G et al. Transplantation outcome in patients on PD and HD. Contrib Nephrol 2006: 150: 259.
17. Kandaswamy R, Keith Melancon J, Dunn TY et al. A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients - an interim analysis. Am J Transplant 2005: 5: 1529.
18. Kumar MSA, Heifets M, Fyfe B et al. Comparison of steroid avoidance in tacrolimus/mycophenolate mofetil and tacrolimus/sirolimus combination in kidney transplantation monitored by surveillance biopsy. Transplantation 2005: 80: 807.
19. Woodle ES, Vincenti F, Lorber MI et al. A multicenter pilot study of eraly (4-day) steroid cessation in renal transplant recipients inder simulest, tacrolimus and sirolimus. Am J Transplant 2005: 5: 157.